A novel class of 4-pyridinoxy-2-anilinopyridine-based TGF-beta type I receptor (also known as activin-like kinase 5 or ALK5) inhibitors is reported. The binding mode of this scaffold was successfully predicted by analyzing possible docked binding modes of literature inhibitors and novel synthetic ideas. Compounds such as 19 are potent ALK5 inhibitors with good physicochemical and pharmacokinetic properties and thus represent high quality leads for further optimization.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/jm900807w | DOI Listing |
Publication Analysis
Top Keywords
high quality
8
tgf-beta type
8
type receptor
8
alk5 inhibitors
8
rapid generation
4
generation high
4
quality lead
4
lead transforming
4
transforming growth
4
growth factor-beta
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!